title: Development of AEZS-115 (ZEN-019) by optimization of structurally unique, orally active, peptidomimetic GnRH antagonists.
authors.affiliation: AEterna Zentaris GmbH, Discovery and Preclinical Development, Weismuellerstr. 50, 60314 Frankfurt am Main, Germany.
authors.forename: K W
authors.initials: KW
authors.lastname: Paulini
authors.forename: S
authors.initials: S
authors.lastname: Baasner
authors.forename: M
authors.initials: M
authors.lastname: Gerlach
authors.forename: E E
authors.initials: EE
authors.lastname: Polymeropoulos
authors.forename: P
authors.initials: P
authors.lastname: Schmidt
authors.forename: T
authors.initials: T
authors.lastname: Schuster
authors.forename: M
authors.initials: M
authors.lastname: Teifel
authors.forename: E G
authors.initials: EG
authors.lastname: Guenther
mesh_terms: D000284:Administration, Oral; D000818:Animals; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006168:Guinea Pigs; D008297:Male; D015394:Molecular Structure; D051381:Rats
chemical_list: D007987:Gonadotropin-Releasing Hormone